Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ProTreat - Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study

NCT03147352 is registered in ClinicalTrials.gov with Ole Hyldegaard as lead sponsor.

NCT NCT03147352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03147352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ProTreat - Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study
Lead sponsor
Ole Hyldegaard
Phase
Observational
Overall status
Completed
Start date
February 28, 2013
Completion date
January 31, 2018
Enrollment
260 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fournier gangrene, gas gangrene, necrotizing fascitis, necrotizing soft tissue infection